Article
Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes.
Diabetes - 1 Dec 2002
Marculescu Rodrig, Endler Georg, Schillinger Martin, Iordanova Nelly, Exner Markus, Hayden Evelyn, Huber Kurt, Wagner Oswald, Mannhalter Christine
Abstract excerpt
Recently, inflammation has received considerable attention in the pathogenesis of both type 2 diabetes and atherosclerosis. The interleukin-1 receptor antagonist (IL-1ra) is a major modulator of the interleukin-1 pro-inflammatory pathway. We studied the relationship between a variable number tandem repeat (VNTR) polymorphism in intron 2 of the IL-1ra gene (IL1RN) and coronary artery disease (CAD) in patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
